Sign Up to like & get
recommendations!
0
Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-125645
Abstract: Background: Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematological malignancy with a poor prognosis. The majority of patients with BPDCN show a complex karyotype. Recurrently mutated genes mainly include epigenetic modifiers and splicing…
read more here.
Keywords:
mll munich;
analysis;
leukemia laboratory;
expression ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-128234
Abstract: Background: AML with myelodysplasia related changes (AML-MRC) is as specific WHO category with poor prognosis. It requires ≥ 20% of blasts, and (1) the history of MDS or MDS/MPN, or (2) "MDS related cytogenetic abnormalities",…
read more here.
Keywords:
mll munich;
aml mrc;
mrc;
leukemia laboratory ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-128488
Abstract: Background: Interpreting the pathogenic potential of an amino-acid changing single nucleotide variant (SNV) in a disease related gene can be challenging, especially for rare variants for which little or no information is available in clinical…
read more here.
Keywords:
mll munich;
laboratory employment;
predictor;
germline ... See more keywords